UnitedHealth (UNH) Stock Forecast & Price Target

Compare

16,474 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UNH Analyst Ratings

Moderate Buy

18 Buy

7 Hold

1 Sell

Based on 26 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

$361.91

▲(17.67%Upside)

Based on 26 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $361.91 with a high forecast of $440.00 and a low forecast of $270.00. The average price target represents a 17.67% change from the last price of $307.56.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"269":"$269","600":"$600","351.75":"$351.8","434.5":"$434.5","517.25":"$517.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":361.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$361.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$270.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[269,351.75,434.5,517.25,600],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,302.57,313.14153846153846,323.7130769230769,334.2846153846154,344.85615384615386,355.4276923076923,365.9992307692308,376.5707692307692,387.14230769230767,397.71384615384613,408.2853846153846,418.85692307692307,429.42846153846153,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,302.57,307.13461538461536,311.6992307692308,316.26384615384615,320.82846153846157,325.39307692307693,329.9576923076923,334.5223076923077,339.0869230769231,343.6515384615385,348.2161538461539,352.78076923076924,357.34538461538466,{"y":361.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,302.57,300.06461538461537,297.55923076923074,295.05384615384617,292.54846153846154,290.0430769230769,287.5376923076923,285.0323076923077,282.5269230769231,280.02153846153846,277.5161538461538,275.01076923076926,272.5053846153846,{"y":270,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":484.14,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":485.48,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":562.16,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":579.26,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":574.52,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":559.02,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":599.36,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":500.16,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":536.37,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":469.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.43,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":397.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.57,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$361.91

Lowest Price Target$270.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$364

Buy

18.35%

Upside

Upgraded

07/02/25

UnitedHealth Group's stock score reflects a strong financial performance and attractive valuation, partially offset by technical challenges and uncertainty from corporate events. The company's robust financial health and strategic growth initiatives in Medicare Advantage and Optum services are significant strengths. However, recent earnings call challenges and management transitions present risks that investors should monitor closely.

A.J. RiceUBS

UBS

$400→$385

Buy

25.18%

Upside

Reiterated

06/25/25

UnitedHealth price target lowered to $385 from $400 at UBSUnitedHealth price target lowered to $385 from $400 at UBS

Lisa GillJ.P. Morgan

J.P. Morgan

$405→$418

Buy

35.91%

Upside

Reiterated

06/19/25

J.P. Morgan Sticks to Its Buy Rating for UnitedHealth (UNH)

Stephen BaxterWells Fargo

Wells Fargo

$418→$351

Buy

14.12%

Upside

Reiterated

06/18/25

UnitedHealth (UNH) Receives a Buy from Wells Fargo

Lance WilkesBernstein

Bernstein

$377

Buy

22.58%

Upside

Assigned

06/17/25

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE) and UnitedHealth (NYSE: UNH)

Ann HynesMizuho Securities

Mizuho Securities

$350

Buy

13.80%

Upside

Reiterated

06/13/25

Mizuho Securities Sticks to Their Buy Rating for UnitedHealth (UNH)

David WindleyJefferies

Jefferies

$400→$399

Buy

29.73%

Upside

Reiterated

06/11/25

Jefferies Remains a Buy on UnitedHealth (UNH)

Michael HaRobert W. Baird

Robert W. Baird

$356→$312

Hold

1.44%

Upside

Downgraded

06/11/25

UnitedHealth downgraded to Neutral from Outperform at BairdUnitedHealth downgraded to Neutral from Outperform at Baird

Joanna GajukBank of America Securities

Bank of America Securities

$350

Hold

13.80%

Upside

Reiterated

06/10/25

UnitedHealth's Margin Challenges and Strategic Focus Lead to Hold Rating

Erin WrightMorgan Stanley

Morgan Stanley

$374

Buy

21.60%

Upside

Reiterated

06/04/25

UnitedHealth's Strategic Positioning and Growth Potential: A Buy Rating Amidst Challenges

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$440

Buy

43.06%

Upside

Reiterated

06/04/25

Cantor Fitzgerald Reaffirms Their Buy Rating on UnitedHealth (UNH)

Jessica TassanPiper Sandler

Piper Sandler

$552→$353

Buy

14.77%

Upside

Reiterated

06/03/25

UnitedHealth (UNH) Gets a Buy from Piper Sandler

Whit MayoLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

06/02/25

UnitedHealth's Strategic Initiatives and Pricing Adjustments Drive Positive Outlook and Buy Rating

Matthew Gillmor CFAKeyBanc

KeyBanc

$450→$400

Buy

30.06%

Upside

Reiterated

06/02/25

UnitedHealth (UNH) Gets a Buy from KeyBanc

Ryan LangstonTD Cowen

TD Cowen

$308

Hold

0.14%

Upside

Reiterated

06/02/25

TD Cowen Remains a Hold on UnitedHealth (UNH)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$364

Buy

18.35%

Upside

Upgraded

07/02/25

A.J. RiceUBS

UBS

$400→$385

Buy

25.18%

Upside

Reiterated

06/25/25

UnitedHealth price target lowered to $385 from $400 at UBSUnitedHealth price target lowered to $385 from $400 at UBS

Lisa GillJ.P. Morgan

J.P. Morgan

$405→$418

Buy

35.91%

Upside

Reiterated

06/19/25

J.P. Morgan Sticks to Its Buy Rating for UnitedHealth (UNH)

Stephen BaxterWells Fargo

Wells Fargo

$418→$351

Buy

14.12%

Upside

Reiterated

06/18/25

UnitedHealth (UNH) Receives a Buy from Wells Fargo

Lance WilkesBernstein

Bernstein

$377

Buy

22.58%

Upside

Assigned

06/17/25

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE) and UnitedHealth (NYSE: UNH)

Ann HynesMizuho Securities

Mizuho Securities

$350

Buy

13.80%

Upside

Reiterated

06/13/25

Mizuho Securities Sticks to Their Buy Rating for UnitedHealth (UNH)

David WindleyJefferies

Jefferies

$400→$399

Buy

29.73%

Upside

Reiterated

06/11/25

Jefferies Remains a Buy on UnitedHealth (UNH)

Michael HaRobert W. Baird

Robert W. Baird

$356→$312

Hold

1.44%

Upside

Downgraded

06/11/25

UnitedHealth downgraded to Neutral from Outperform at BairdUnitedHealth downgraded to Neutral from Outperform at Baird

Joanna GajukBank of America Securities

Bank of America Securities

$350

Hold

13.80%

Upside

Reiterated

06/10/25

UnitedHealth's Margin Challenges and Strategic Focus Lead to Hold Rating

Erin WrightMorgan Stanley

Morgan Stanley

$374

Buy

21.60%

Upside

Reiterated

06/04/25

UnitedHealth's Strategic Positioning and Growth Potential: A Buy Rating Amidst Challenges

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$440

Buy

43.06%

Upside

Reiterated

06/04/25

Cantor Fitzgerald Reaffirms Their Buy Rating on UnitedHealth (UNH)

Jessica TassanPiper Sandler

Piper Sandler

$552→$353

Buy

14.77%

Upside

Reiterated

06/03/25

UnitedHealth (UNH) Gets a Buy from Piper Sandler

Whit MayoLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

06/02/25

UnitedHealth's Strategic Initiatives and Pricing Adjustments Drive Positive Outlook and Buy Rating

Matthew Gillmor CFAKeyBanc

KeyBanc

$450→$400

Buy

30.06%

Upside

Reiterated

06/02/25

UnitedHealth (UNH) Gets a Buy from KeyBanc

Ryan LangstonTD Cowen

TD Cowen

$308

Hold

0.14%

Upside

Reiterated

06/02/25

TD Cowen Remains a Hold on UnitedHealth (UNH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

1 Month

xxx

Success Rate

22/31 ratings generated profit

Average Return

+1.50%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 70.97% of your transactions generating a profit, with an average return of +1.50% per trade.

3 Months

xxx

Success Rate

21/31 ratings generated profit

Average Return

+2.79%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +2.79% per trade.

1 Year

Scott FidelStephens

Success Rate

36/43 ratings generated profit

Average Return

+20.81%

reiterated a buy rating 2 months ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 83.72% of your transactions generating a profit, with an average return of +20.81% per trade.

2 Years

xxx

Success Rate

36/40 ratings generated profit

Average Return

+45.52%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +45.52% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UNH has received 71 Buy Ratings, 13 Hold Ratings, and 1 Sell Ratings. UNH average Analyst price target in the past 3 months is 361.91.

Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is $4.96 with a range of $3.92 to $5.79. The previous quarter’s EPS was $7.20. UNH beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is $111.72B with a range of $110.02B to $115.54B. The previous quarter’s sales results were $109.58B. UNH beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year UNH has Outperformed its overall industry.

UNH Stock Forecast FAQ

What is UNH’s average 12-month price target, according to analysts?

Based on analyst ratings, UnitedHealth’s 12-month average price target is 361.91.

What is UNH’s upside potential, based on the analysts’ average price target?

UnitedHealth has 17.67% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UNH a Buy, Sell or Hold?

UnitedHealth has a consensus rating of Moderate Buy which is based on 18 buy ratings, 7 hold ratings and 1 sell ratings.

What is UnitedHealth’s price target?

The average price target for UnitedHealth is 361.91. This is based on 26 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $440.00 ,the lowest forecast is $270.00. The average price target represents 17.67% Increase from the current price of $307.56.

What do analysts say about UnitedHealth?

UnitedHealth’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 26 Wall Streets Analysts.

How can I buy shares of UNH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

UnitedHealth (UNH) Stock Forecast & Price Target

UNH Analyst Ratings

UNH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

UNH Analyst Recommendation Trends

UNH Financial Forecast

UNH Earnings Forecast

UNH Sales Forecast

UNH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts